PDL BioPharma (PDLI) Declares $0.15 Quarterly Dividend; 8.3% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
PDL BioPharma Completes Regular Quarterly Dividend Payment
March 12, 2015 4:02 PM EDTINCLINE VILLAGE, Nev., March 12, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the March 12, 2015, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of March 5, 2015, the record date.
About PDL BioPharmaPDL manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents,... More
